Four-Month High-Dose Rifampicin Regimens for Pulmonary Tuberculosis.

Autor: Jindani A; Institute for Infection and Immunity, St. George's, University of London, London., Atwine D; Epicentre/Mbarara Research Base, Mbarara, Uganda.; Mbarara University of Science and Technology, Mbarara, Uganda., Grint D; London School of Hygiene and Tropical Medicine, London., Bah B; Centre Hospitalier Universitaire Ignace Deen, Conakry, Guinea., Adams J; Institute for Infection and Immunity, St. George's, University of London, London., Ticona ER; Hospital Nacional Dos de Mayo, Universidad Nacional Mayor de San Marcos, Lima, Peru., Shrestha B; German Nepal TB Project (GENETUP)/Nepal Anti TB Association (NATA), Kathmandu, Nepal., Agizew T; University of Botswana, Gaborone, Botswana., Hamid S; Aga Khan University Hospital, Karachi, Pakistan., Jamil B; Aga Khan University Hospital, Karachi, Pakistan., Byamukama A; Epicentre/Mbarara Research Base, Mbarara, Uganda., Kananura K; Epicentre/Mbarara Research Base, Mbarara, Uganda., Mugisha Taremwa I; Epicentre/Mbarara Research Base, Mbarara, Uganda., Bonnet M; Epicentre/Mbarara Research Base, Mbarara, Uganda.; University of Montpellier, Recherche translationelles sur le virus de l'immunodéficience humaine et les maladies infectieuses, Institut de recherche pour le developpement, Institut national de la santé et de la recherche médicale, Montpellier, France., Camara LM; Centre Hospitalier Universitaire Ignace Deen, Conakry, Guinea., Bah-Sow OY; Centre Hospitalier Universitaire Ignace Deen, Conakry, Guinea., Bah KS; Centre Hospitalier Universitaire Ignace Deen, Conakry, Guinea., Bah NM; Centre Hospitalier Universitaire Ignace Deen, Conakry, Guinea., Sow M; Centre Hospitalier Universitaire Ignace Deen, Conakry, Guinea., Ticona Huaroto CE; Hospital Nacional Dos de Mayo, Universidad Nacional Mayor de San Marcos, Lima, Peru., Mugruza Pineda R; Hospital Nacional Dos de Mayo, Universidad Nacional Mayor de San Marcos, Lima, Peru., Tandukar B; German Nepal TB Project (GENETUP)/Nepal Anti TB Association (NATA), Kathmandu, Nepal., Raya BB; German Nepal TB Project (GENETUP)/Nepal Anti TB Association (NATA), Kathmandu, Nepal., Shrestha N; German Nepal TB Project (GENETUP)/Nepal Anti TB Association (NATA), Kathmandu, Nepal., Mathoma A; University of Botswana, Gaborone, Botswana., Mathebula-Modongo UP; University of Botswana, Gaborone, Botswana., Basotli J; University of Botswana, Gaborone, Botswana., Irfan M; Aga Khan University Hospital, Karachi, Pakistan., Begum D; Aga Khan University Hospital, Karachi, Pakistan., Muzammil A; Aga Khan University Hospital, Karachi, Pakistan., Ahmed I; Aga Khan University Hospital, Karachi, Pakistan., Hasan R; Aga Khan University Hospital, Karachi, Pakistan., Burgos MV; Division of Infectious Diseases, University of New Mexico, Albuquerque, NM., Sultan F; Shaukat Khanum Research Centre and Cancer Hospital, Lahore, Pakistan., Hassan M; Shaukat Khanum Research Centre and Cancer Hospital, Lahore, Pakistan., Masood I; Shaukat Khanum Research Centre and Cancer Hospital, Lahore, Pakistan., Robb C; Institute for Infection and Immunity, St. George's, University of London, London., Decker J; Department of Respiratory Sciences, University of Leicester, Leicester, United Kingdom., Grubnic S; Clinical Academic Group in Infection and Immunity, St. George's University Hospitals National Health Service Foundation Trust, London., Butcher PD; Institute for Infection and Immunity, St. George's, University of London, London., Witney A; Institute for Infection and Immunity, St. George's, University of London, London., Dhillon J; Institute for Infection and Immunity, St. George's, University of London, London., Munshi T; Institute for Infection and Immunity, St. George's, University of London, London., Fielding K; London School of Hygiene and Tropical Medicine, London., Harrison TS; Institute for Infection and Immunity, St. George's, University of London, London.; Clinical Academic Group in Infection and Immunity, St. George's University Hospitals National Health Service Foundation Trust, London.; Medical Reserach Council Centre for Medical Mycology, University of Exeter, Exeter, United Kingdom.

Publikováno v: NEJM evidence [NEJM Evid] 2023 Sep; Vol. 2 (9), pp. EVIDoa2300054. Date of Electronic Publication: 2023 Aug 22.

Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study.

Autor: Auld AF; Division of Global HIV & TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Kerkhoff AD; Division of HIV, Infectious Diseases and Global Medicine at Zuckerberg San Francisco General Hospital and Trauma Center, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America., Hanifa Y; TB Centre, London School of Hygiene & Tropical Medicine, London, United Kingdom., Wood R; The Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, Cape Town, South Africa., Charalambous S; Aurum Institute, Johannesburg, South Africa., Liu Y; Division of Global HIV & TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Agizew T; Division of TB Elimination, Centers for Disease Control and Prevention, Gaborone, Botswana., Mathoma A; Division of TB Elimination, Centers for Disease Control and Prevention, Gaborone, Botswana.; University of Botswana, Gaborone, Botswana., Boyd R; Division of TB Elimination, Centers for Disease Control and Prevention, Gaborone, Botswana., Date A; Division of Global HIV & TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Shiraishi RW; Division of Global HIV & TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Bicego G; Division of Global HIV & TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Mathebula-Modongo U; Division of TB Elimination, Centers for Disease Control and Prevention, Gaborone, Botswana., Alexander H; Division of Global HIV & TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Serumola C; Division of TB Elimination, Centers for Disease Control and Prevention, Gaborone, Botswana., Rankgoane-Pono G; Ministry of Health and Wellness, Gaborone, Botswana., Pono P; Ministry of Health and Wellness, Gaborone, Botswana., Finlay A; Division of TB Elimination, Centers for Disease Control and Prevention, Gaborone, Botswana., Shepherd JC; Division of TB Elimination, Centers for Disease Control and Prevention, Gaborone, Botswana.; Yale University School of Medicine, New Haven, Connecticut, United States of America., Ellerbrock TV; Division of Global HIV & TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Grant AD; TB Centre, London School of Hygiene & Tropical Medicine, London, United Kingdom.; Africa Health Research Institute, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa., Fielding K; TB Centre, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Publikováno v: PLoS medicine [PLoS Med] 2021 Sep 07; Vol. 18 (9), pp. e1003739. Date of Electronic Publication: 2021 Sep 07 (Print Publication: 2021).

The Impact of GeneXpert Cerebrospinal Fluid Testing on Tuberculous Meningitis Diagnosis in Routine Care in Botswana.

Autor: Milburn, James^1,2 (AUTHOR) james.milburn@lshtm.ac.uk, Ntwayagae, Ookeditse³ (AUTHOR), Ngoni, Kebatshabile¹ (AUTHOR), Suresh, Rachita¹ (AUTHOR), Lemme, Neo^4,5 (AUTHOR), Northcott, Cassie¹ (AUTHOR), Penney, James¹ (AUTHOR), Kinsella, Matthew¹ (AUTHOR), Mechie, Imogen¹ (AUTHOR), Ensor, Samuel¹ (AUTHOR), Chebani, Tony⁶ (AUTHOR), Grint, Daniel⁷ (AUTHOR), Tenforde, Mark W⁸ (AUTHOR), Avalos, Ava¹ (AUTHOR), Ramaabya, Dinah⁶ (AUTHOR), Doyle, Ronan² (AUTHOR), Mokomane, Margaret⁹ (AUTHOR), Mine, Madisa⁴ (AUTHOR), Kranzer, Katharina^2,10,11 (AUTHOR), Jarvis, Joseph N^1,2 (AUTHOR)

Publikováno v: Open Forum Infectious Diseases. Sep2024, Vol. 11 Issue 9, p1-8. 8p.

Contribution of Xpert ^® MTB/RIF to tuberculosis case finding among pregnant women in Botswana.

Autor: Hamda SG; Faculty of Medicine, Department of Family Medicine and Public Health, University of Botswana, Gaborone, Botswana., Tshikuka JG; Faculty of Medicine, Department of Family Medicine and Public Health, University of Botswana, Gaborone, Botswana.; Faculty of Health Sciences, National Pedagogic University, Kinshasa, Democratic Republic of Congo., Joel D; Faculty of Medicine, Department of Paediatrics, University of Botswana, Gaborone, Botswana., Setlhare V; Faculty of Medicine, Department of Family Medicine and Public Health, University of Botswana, Gaborone, Botswana., Monamodi G; Faculty of Medicine, Department of Family Medicine and Public Health, University of Botswana, Gaborone, Botswana., Mbeha B; Botswana National Tuberculosis Reference Laboratory, Ministry of Health and Wellness, Gaborone, Botswana., Tembo BP; Botswana National Tuberculosis Reference Laboratory, Ministry of Health and Wellness, Gaborone, Botswana., Mulenga F; Botswana National Tuberculosis Reference Laboratory, Ministry of Health and Wellness, Gaborone, Botswana., Agizew T; Faculty of Medicine, Department of Family Medicine and Public Health, University of Botswana, Gaborone, Botswana.

Publikováno v: Public health action [Public Health Action] 2020 Jun 21; Vol. 10 (2), pp. 76-81.

Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria.

Autor: Agizew T; U.S. Centers for Disease Control and Prevention (CDC), Gaborone, Botswana.; Department of Family Medicine and Public Health, Faculty of Medicine, University of Botswana, Gaborone, Botswana.; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Boyd R; U.S. Centers for Disease Control and Prevention (CDC), Gaborone, Botswana.; Division of Tuberculosis Elimination, CDC, Atlanta, Georgia, United States of America., Mathebula U; U.S. Centers for Disease Control and Prevention (CDC), Gaborone, Botswana., Mathoma A; U.S. Centers for Disease Control and Prevention (CDC), Gaborone, Botswana., Basotli J; U.S. Centers for Disease Control and Prevention (CDC), Gaborone, Botswana., Serumola C; U.S. Centers for Disease Control and Prevention (CDC), Gaborone, Botswana., Pals S; Division of Global HIV/AIDS and Tuberculosis, CDC, Atlanta, Georgia, United States of America., Finlay A; U.S. Centers for Disease Control and Prevention (CDC), Gaborone, Botswana.; Division of Tuberculosis Elimination, CDC, Atlanta, Georgia, United States of America., Lekone P; U.S. Centers for Disease Control and Prevention (CDC), Gaborone, Botswana., Rankgoane-Pono G; Ministry of Health and Wellness, National Tuberculosis Control Programme, Gaborone, Botswana., Tlhakanelo T; Department of Family Medicine and Public Health, Faculty of Medicine, University of Botswana, Gaborone, Botswana., Chihota V; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Aurum Institute, Johannesburg, South Africa., Auld AF; Division of Global HIV/AIDS and Tuberculosis, CDC, Atlanta, Georgia, United States of America.

Publikováno v: PloS one [PLoS One] 2020 Jun 12; Vol. 15 (6), pp. e0234646. Date of Electronic Publication: 2020 Jun 12 (Print Publication: 2020).